Zeto closed a $31 million funding round to support its AI-driven EEG brain monitoring technology. MindWorks Global (MWG) led the financing. Zeto plans to use funds to expand its commercial and operational teams, drive growth and strengthen R&D efforts.
Santa Clara, California–based Zeto develops the FDA-cleared One system. One features a user-friendly headset equipped with 21 soft-tip electrodes positioned according to the commonly followed 10-20 EEG system. Intuitive LED feedback accompanies the headset for easy adjustments as well.
Related: Francis Medical raises $80M Series C for water vapor ablation tech
The technology requires minimal training for healthcare professionals to operate effectively. The portable recording device captures patient video and audio and offers display and recording controls. It also features live, AI-enabled notifications for seizure activity which can prove crucial in critical emergency scenarios.
Zeto says One seamlessly streams data to its Zeto Cloud, enabling live remote interpretations by board-certified neurologists. On top of point-of-care capabilities, One serves as a comprehensive EEG platform. It enables various tasks, including workflow management, patient scheduling and report generation.
“Zeto has reached a pivotal milestone, earning a reputation for game-changing innovation and experiencing rapid adoption of our solutions by leading healthcare institutions across the U.S.,” said Aswin Gunasekar, founder and CEO. “Our management team has long aspired to collaborate with accomplished entrepreneur-investors who have successfully scaled companies to drive meaningful societal impact and significant revenue.
“We are excited to welcome MindWorks Global partners to our board of directors who bring not only capital but also invaluable expertise, extensive experience, and a powerful network. Our dedicated team is eager to embark on this exciting next chapter in our company’s journey.”
